Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells
- 17 July 2000
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1497 (2), 215-226
- https://doi.org/10.1016/s0167-4889(00)00062-8
Abstract
We examined transforming growth factor (TGF) α, epidermal growth factor (EGF) and EGF receptor (EGFR) expression and signaling in three drug resistant MCF-7 human breast cancer sublines and asked whether these pathways contribute to the drug resistance phenotype. In the resistant sublines, upregulation of both TGFα and EGFR mRNA was observed. In an apparent contrast with upregulated growth factor and receptor gene expression, the drug resistant sublines displayed a reduced growth rate. Defects in the EGFR signaling pathway cascade were found in all examined drug resistant sublines, including altered EGF-induced Shc, Raf-1, or mitogen-activated protein kinase phosphorylation. Induction of c-fos mRNA expression by EGF was impaired in the sublines compared to parental MCF-7 cells. In contrast, the induction of the stress-activated protein kinase activity was similar in both parental and drug resistant cells. Evaluating the link between the reduced growth rate and drug resistance, serum starvation experiments were performed. These studies demonstrated that a reduced proliferative activity resulted in a marked reduction in sensitivity to cytotoxic agents in the parental MCF-7 cells. We propose that the altered EGFR levels frequently observed in drug resistant breast cancer cells are associated with perturbations in the signaling pathway that mediate a reduced proliferative rate and thereby contribute to drug resistance.Keywords
This publication has 37 references indexed in Scilit:
- Cellular survival: a play in three AktsGenes & Development, 1999
- Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cellsEuropean Journal of Cell Biology, 1999
- Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profileJournal of Clinical Pathology, 1998
- Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transductionNature, 1995
- The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathwayCell, 1995
- Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal AntibodiesJNCI Journal of the National Cancer Institute, 1993
- Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neuBreast Cancer Research and Treatment, 1992
- In vitro effect of doxorubicin on non-proliferating and proliferating epithelial cellsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- PREDICTIVE VALUE OF EGF RECEPTOR IN BREAST CANCERThe Lancet, 1988
- Human epidermal growth factor precursor: cDNA sequence, expressionin vitroand gene organizationNucleic Acids Research, 1986